The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside

Biotech stocks are not for the faint of heart, as companies in the clinical stage push risk to the extreme. With key clinical data still to come, huge financial burn, and valuation almost entirely dependent on trial outcomes, these companies only offer massive upside if everything goes as planned. Here are two of the riskiest biotech stocks investors are betting on. Biotech Stock #1: Opus Genetics Opus Genetics (IRD) has emerged as one of the boldest and riskiest bets investors are making right now. Val ...